Zverev fights against pneumonia - Masters in Shanghai remains safe!

Zverev fights against pneumonia - Masters in Shanghai remains safe!

tennis professional Alexander Zverev gave an insight into his health and found some thoughtful words about his lung disease. The 27-year-old said: "The problem I have with my lung will not go away within a week or two. It will probably take a month or two." This statement underlines the severity of the situation with which the Hamburg native is faced.

In a current video update, Zverev reported that he had now received the right medication for his pneumonia. "I hope it will get better every week," he added optimistically. Despite the health challenges, the tennis player remains confident and determined to fight back.

Participation in the Masters in Shanghai

Fortunately, it was announced that Zverev's participation in the upcoming Masters tournament in Shanghai is not at risk. According to his doctors, his condition will not worsen if he continues to do sports. "I will start at the Masters in Shanghai on Wednesday," he informed his fans. In the impressive metropolis of millions, Zverev is in place behind the Italian player Jannik Sinner, who is currently leading the world rankings. In the first round of the tournament, the Tokyo Olympic champion has a free time and will then compete against a qualifier.

Zverev's decision to take part in the Masters tournament came after the tournament in Beijing. He admitted that he felt much uncomfortable during and after the Laver Cup. This honest reflection shows that athletes are not immune to health setbacks and illustrates the challenges with which they are confronted. If his progress continues, it remains to be seen how his performance will develop in the upcoming events.

Zverev's experience could be inspiring for many of his fans, because it testifies to determination in difficult times. The professional sees a ray of hope in his medical care and puts his hope for better health, while at the same time concentrating on his career in tennis. For more detailed information about his progress and other developments, Read the article on www.shz.de .